Outcomes of Drug Resistant Epileptic Pediatric Patient by Modified Atkins Diet
ConditionDrug Resistant Epilepsy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorSohag University
About this trial
To assess clinical outcomes in drug resistant epileptic pediatric patient by modified atkin diet with focusing on following points:
1. Control of seizures(frequency , duration and numbers of hospital admissions) . 2. Quality of life by pediatric quality of life inventory v4. 3. Cognitive function by stanford binet intelligence scale 5th edition. 4. Growth parameters ( weight, height will be combined to report BMI in kg/m\^2).
Eligibility criteria
Qualifiers
Children aged 1-18 years.
Diagnosed with drug-resistant epilepsy according to ILAE definition.[2]
On KD for at least 6 months.
Disqualifiers
- Patients with contraindicated metabolic/genetic conditions.
Non-compliance with KD .
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov